Carl Hull, who was Gen-Probe CEO when Bedford, MA-based Hologic agreed to pay $3.7 billion to acquire the San Diego diagnostics company in 2012, has embarked on a new venture backed by GTCR, the Chicago private equity firm. Hull and Eric Tardif, a former investment banker who was a managing director at Gen-Probe, founded San Diego-based Maravai Life Sciences in a partnership with GTCR to roll up businesses focused on biomedical diagnostics and life sciences tools. Together, they plan to acquire companies that are aligned with their strategy, with GTCR investing as much as $300 million.
Help employers find you! Check out all the jobs and post your resume.
